Haverford Trust Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
29,887
-507
-2% -$181K 0.1% 101
2025
Q4
$9.95M Sell
30,394
-233
-0.8% -$73.9K 0.09% 102
2025
Q3
$8.64M Sell
30,627
-11,019
-26% -$3.2M 0.08% 106
2025
Q2
$11.6M Sell
41,646
-388
-0.9% -$110K 0.11% 97
2025
Q1
$13.1M Sell
42,034
-265
-0.6% -$78.3K 0.13% 91
2024
Q4
$11M Sell
42,299
-571
-1% -$169K 0.11% 94
2024
Q3
$13.8M Buy
42,870
+346
+0.8% +$113K 0.13% 92
2024
Q2
$13.3M Buy
42,524
+3,853
+10% +$1.13M 0.14% 90
2024
Q1
$11M Sell
38,671
-536
-1% -$157K 0.11% 99
2023
Q4
$11.3M Buy
39,207
+837
+2% +$228K 0.13% 96
2023
Q3
$10.3M Sell
38,370
-55
-0.1% -$13.7K 0.13% 93
2023
Q2
$8.53M Sell
38,425
-512
-1% -$119K 0.1% 94
2023
Q1
$9.41M Sell
38,937
-2,605
-6% -$639K 0.11% 88
2022
Q4
$10.9M Sell
41,542
-640
-2% -$172K 0.13% 84
2022
Q3
$9.51M Sell
42,182
-1,037
-2% -$251K 0.13% 85
2022
Q2
$10.5M Sell
43,219
-290
-0.7% -$71.1K 0.14% 84
2022
Q1
$10.5M Sell
43,509
-2,866
-6% -$658K 0.12% 91
2021
Q4
$10.4M Sell
46,375
-3,313
-7% -$699K 0.11% 89
2021
Q3
$10.6M Sell
49,688
-2,400
-5% -$552K 0.13% 86
2021
Q2
$12.7M Buy
52,088
+6,357
+14% +$1.56M 0.15% 78
2021
Q1
$11.4M Sell
45,731
-824
-2% -$197K 0.15% 75
2020
Q4
$10.7M Sell
46,555
-15,699
-25% -$3.62M 0.15% 72
2020
Q3
$15.8M Buy
62,254
+272
+0.4% +$67.4K 0.25% 61
2020
Q2
$14.6M Sell
61,982
-4,082
-6% -$931K 0.25% 62
2020
Q1
$13.4M Sell
66,064
-1,734
-3% -$379K 0.27% 64
2019
Q4
$16.3M Buy
67,798
+847
+1% +$187K 0.26% 69
2019
Q3
$13M Sell
66,951
-31
-0% -$5.95K 0.23% 73
2019
Q2
$12.3M Sell
66,982
-330
-0.5% -$59.1K 0.22% 72
2019
Q1
$12.8M Sell
67,312
-453
-0.7% -$86.5K 0.24% 70
2018
Q4
$13.2M Buy
67,765
+397
+0.6% +$77.5K 0.28% 65
2018
Q3
$14M Sell
67,368
-102
-0.2% -$20.1K 0.26% 66
2018
Q2
$12.5M Sell
67,470
-48
-0.1% -$8.49K 0.25% 67
2018
Q1
$11.5M Sell
67,518
-402
-0.6% -$73.8K 0.23% 66
2017
Q4
$11.8M Buy
67,920
+4,592
+7% +$813K 0.23% 65
2017
Q3
$11.8M Buy
63,328
+582
+0.9% +$103K 0.25% 63
2017
Q2
$10.8M Buy
62,746
+824
+1% +$134K 0.24% 63
2017
Q1
$10.2M Buy
61,922
+821
+1% +$136K 0.23% 63
2016
Q4
$8.93M Buy
61,101
+22,654
+59% +$3.41M 0.22% 67
2016
Q3
$6.41M Buy
38,447
+29
+0.1% +$4.9K 0.16% 68
2016
Q2
$5.84M Sell
38,418
-99
-0.3% -$15.4K 0.15% 72
2016
Q1
$5.78M Hold
38,517
0.15% 70
2015
Q4
$6.25M Buy
38,517
+4,898
+15% +$770K 0.17% 70
2015
Q3
$4.65M Buy
33,619
+3,650
+12% +$575K 0.14% 69
2015
Q2
$4.6M Buy
29,969
+2,545
+9% +$408K 0.13% 71
2015
Q1
$4.38M Buy
27,424
+1,613
+6% +$254K 0.12% 76
2014
Q4
$4.11M Buy
25,811
+552
+2% +$86K 0.12% 81
2014
Q3
$3.55M Buy
25,259
+360
+1% +$47K 0.11% 79
2014
Q2
$2.95M Buy
24,899
+1,475
+6% +$171K 0.09% 83
2014
Q1
$2.89M Sell
23,424
-284
-1% -$34.4K 0.09% 81
2013
Q4
$2.71M Buy
23,708
+601
+3% +$68.4K 0.08% 91
2013
Q3
$2.59M Buy
23,107
+4,500
+24% +$488K 0.09% 69
2013
Q2
$1.84M Buy
+18,607
New +$1.93M 0.06% 94

Other funds holding AMGN

Haverford Trust Company's AMGN Position: Q1 2026 in Review

Haverford Trust Company reduced its Amgen (AMGN) stake by 1.7% in Q1 2026, selling an estimated $181K and leaving 29,887 shares worth $10.5M. The position accounts for 0.1% of the portfolio, ranked #101.

Haverford Trust Company first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.3M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Haverford Trust Company held 29,887 shares of Amgen worth $10.5M as of Q1 2026.
  • Haverford Trust Company sold 507 Amgen shares in Q1 2026, an estimated $181K.
  • Amgen made up 0.1% of Haverford Trust Company's portfolio in Q1 2026, its #101 holding.
  • Haverford Trust Company first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Haverford Trust Company's Amgen position peaked at $16.3M in Q4 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.